📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer. (2017)

First Author: Chia SL

Attributed to: Translational development of oncolytic Newcastle Disease Virus for treatment of colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.virol.2017.02.011

PubMed Identifier: 28260622

Publication URI: http://europepmc.org/abstract/MED/28260622

Type: Journal Article/Review

Volume: 505

Parent Publication: Virology

ISSN: 0042-6822